Janus Henderson Group PLC Roivant Sciences Ltd. Transaction History
Janus Henderson Group PLC
- $174 Billion
- Q1 2025
A detailed history of Janus Henderson Group PLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Janus Henderson Group PLC holds 160,443 shares of ROIV stock, worth $1.76 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
160,443
Previous 175,143
8.39%
Holding current value
$1.76 Million
Previous $2.07 Million
21.87%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ROIV
# of Institutions
331Shares Held
496MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$723 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$680 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$506 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$448 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$395 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.74B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...